New hypertension drug ADX-850 enters first human safety trial
NCT ID NCT06205628
First seen Jan 07, 2026 · Last updated May 22, 2026 · Updated 21 times
Summary
This early-stage study tests a new medicine called ADX-850 in 28 adults with mild to moderate high blood pressure. The main goal is to check if the drug is safe and how the body processes it. Researchers will also measure changes in blood pressure over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CMAX Clinical Research
Adelaide, South Australia, 5000, Australia
-
Clinitrials Pty Ltd
Perth, Australia
-
Linear Clinical Research
Nedlands, Western Australia, 6009, Australia
Conditions
Explore the condition pages connected to this study.